当前您的位置： 首页 > 英文站 > Research Support > Core Facilities > Cores > Biotherapy Development Core
Research Support
Biotherapy Development Core
Biotherapy Development Core mainly includes cell therapy, gene therapy and immunotherapy. It possesses a GMP laboratory that accords with the requirements of clinical treatment standards, and is provided with facilities and equipments such as bioreactor, biosafety cabinet, blood cell separator and cell sorter. The platform will provide safe and qualified biotherapy products for clinical trials, and promote the clinical transformation of scientific achievements.
Director: Yueying Wang
GMP Lab
According to international and domestic professional standards, we have established a super clean GMP labora- tory that accords with the requirements of clinical treatment standards. It provides infrastructure for the clinical transformation of biotherapy research projects.
Management System of GMP Core
According to the requirements of GMP production quality management standard, a strict and standardized management system should be established. There is a clear division of labor, process and record for each link in the production process, as well as strict examination and approval links, in which any change can be traced back to the source, with evidences to check and evidences to rely on.
Promoting Clinical Transformation Research
Based on the development of potential biotherapy products, as well as the validation of clinical efficacy and safety by preclinical trials, we will optimize and expand the production process of biotherapy products, and produce safe and qualified products by using our GMP platform, thus providing reliable technical services for the development of high-level clinical transformation research.
Contact
Shuxian Yao
Email: yaoshuxianxian@163.com
闵行基地：上海市闵行区东川路800号
瑞金基地：上海市黄浦区瑞金二路197号
COPYRIGHT © 上海交通大学转化医学研究院
